The Liver Meeting® is protected by copyright, trademark, and/ or other applicable laws. Any use of The Liver Meeting®, including recordings and the development of derivative works, is prohibited. The name, logo and acronym of the American Association for the Study of Liver Diseases and The Liver Meeting® are the exclusive property of and are trademarked by AASLD. They may not be used in any way, for any purpose, or at any time (including but not limited to announcements, invitations, emails, Web publications, etc.) without the express written permission of AASLD.
Without limiting the foregoing, information presented during The Liver Meeting® is the property of AASLD and the presenter. Information may not be recorded, photographed, copied, photocopied, transferred to electronic format, reproduced, or distributed without the written permission of AASLD and the presenter. Any use of the program content which includes, but is not limited to, oral presentations, audiovisual materials used by speakers, and program handouts, without the written consent of AASLD is prohibited.
Notwithstanding the above, AASLD grants a non-exclusive, non-transferable, royalty-free license to nonprofit, 501(c)(3), AAMC-accredited educational institutions to conduct a “Best of AASLD” conference or similar event (“Event”) of up to eight (8) hours in length that features highlights from AASLD sessions at the most recent occurrence of The Liver Meeting® and to utilize the name of AASLD in connection with the same. No Event may be held, nor may the name of AASLD be utilized, except pursuant to this Limited License or as otherwise authorized by AASLD in writing.
When using the term “AASLD” or “The Liver Meeting®”, you must attribute AASLD’s trademark as follows: The Liver Meeting® and AASLD are registered trademarks of the American Association for the Study of Liver Diseases. You may not use the AASLD trademark(s):
All Event announcements, brochures, descriptions, and materials, whether in print or electronic form, shall clearly identify the content as being derived from AASLD sessions by including the following statement: “All content is derived from presentations and similar offerings made at The Liver Meeting® and is presented with permission of the American Association for the Study of Liver Diseases.” As between AASLD and any institution, AASLD is the owner of all AASLD programming and AASLD does not relinquish any such ownership rights by virtue of this Limited License.
AASLD disclaims all warranties, express and implied, as to any information or materials presented in connection with any AASLD session or meeting, including as to intellectual property ownership. AASLD shall not be liable for any direct, indirect, punitive, consequential or other damages in any way arising or resulting from the Event or the use of information or materials from AASLD sessions by any institution. Should any claim or suit be brought against AASLD arising from an Event, the institution shall indemnify and hold AASLD harmless for any damages, liability, and costs, including attorney fees, suffered or incurred by AASLD in defense and satisfaction thereof.
This Limited License does not create a partnership, joint venture or similar relationship between AASLD and any institution. This Limited License is non-transferable, including by sale or sublicense.
This Limited License shall terminate automatically upon violation of any of its terms. In addition, AASLD may terminate, or modify the terms of, this Limited License in its discretion, generally or with respect to any particular institution.
This Limited License shall be construed in accordance with the laws of the Commonwealth of Virginia, without regard to conflicts principles, and, as applicable, federal copyright and trademark laws. A court of competent jurisdiction in or for Alexandria, Virginia shall be the exclusive forum for the resolution of any dispute between AASLD and any institution, and institutions irrevocably consent to the personal and subject matter jurisdiction, and venue, of such court.
When citing an abstract, please use the following format:
Desai RJ, Schnitzler MA, Di Bisceglie AM. Estimated impact of screening and anitviral treatment on prevention of HBV reactiva- tion associated with cancer chemotherapy [Abstract]. Hepatology 2014, 60(4Suppl.1):[Page]A.
Information presented during The Liver Meeting is the property of AASLD and the presenter. Information may not be recorded, photographed, copied, photocopied, transferred to an electronic format, reproduced or distributed without the written permission of AASLD and the presenter. Any use of the program content, which includes, but is not limited to, oral presentations, audiovisual materials used by speakers and program handouts, without consent is prohibited.